16-89919724-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002386.4(MC1R):āc.466G>Cā(p.Val156Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000835 in 1,606,168 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_002386.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC1R | NM_002386.4 | c.466G>C | p.Val156Leu | missense_variant | 1/1 | ENST00000555147.2 | NP_002377.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC1R | ENST00000555147.2 | c.466G>C | p.Val156Leu | missense_variant | 1/1 | NM_002386.4 | ENSP00000451605 | P1 | ||
MC1R | ENST00000555427.1 | c.466G>C | p.Val156Leu | missense_variant | 3/4 | 5 | ENSP00000451760 | |||
MC1R | ENST00000639847.1 | c.466G>C | p.Val156Leu | missense_variant | 3/3 | 5 | ENSP00000492011 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00467 AC: 711AN: 152242Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.00111 AC: 269AN: 241902Hom.: 1 AF XY: 0.000932 AC XY: 123AN XY: 131972
GnomAD4 exome AF: 0.000432 AC: 628AN: 1453808Hom.: 7 Cov.: 34 AF XY: 0.000350 AC XY: 253AN XY: 723576
GnomAD4 genome AF: 0.00468 AC: 713AN: 152360Hom.: 4 Cov.: 33 AF XY: 0.00439 AC XY: 327AN XY: 74498
ClinVar
Submissions by phenotype
Melanoma, cutaneous malignant, susceptibility to, 5 Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | MC1R: BP4, BS1, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 11, 2021 | This variant is associated with the following publications: (PMID: 32163215, 23647022) - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Tyrosinase-positive oculocutaneous albinism;C1849452:Skin/hair/eye pigmentation, variation in, 2;C2751295:Melanoma, cutaneous malignant, susceptibility to, 5;C2751296:Increased analgesia from kappa-opioid receptor agonist, female-specific Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 27, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at